Waikato District Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arora, Reenu
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Completed
2
302
Europe, Canada, US, RoW
Placebo Comparator, ASLAN004
ASLAN Pharmaceuticals
Atopic Dermatitis
06/23
09/23
NCT06302426: Trial of INI-4001 in Patients With Advanced Solid Tumours

Not yet recruiting
1
50
RoW
INI-4001, Nivolumab, Opdivo, Pembrolizumab, Keytruda, Cemiplimab, Libtayo, Avelumab, Bavencio, Atezolizumab, Tecentriq, Durvalumab, Imfinzi
Inimmune Corporation, Avance Clinical Pty Ltd.
Advanced Solid Tumor
08/24
04/26
Khashram, Manar
PREVISION, NCT05556681: Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries

Active, not recruiting
N/A
34
RoW
BD™ Sirolimus Drug Coated Balloon Catheter percutaneous transluminal angioplasty
C. R. Bard
Peripheral Arterial Disease, Peripheral Artery Disease, Stenosis Artery
06/24
12/25
NCT05954793: A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)

Recruiting
N/A
30
RoW
JOTEC GmbH
Thoracoabdominal Aortic Aneurysm
08/24
01/25
WRAP, NCT05062291: Merit SODY™ Endoprosthesis for Treatment of Stenosis or Occlusion

Recruiting
N/A
500
Europe, RoW
Merit WRAPSODY Endovascular Stent Graft
Merit Medical Systems, Inc.
Venous Stenosis, Venous Occlusion
12/25
07/27
Efemoral I, NCT04584632: The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery

Recruiting
N/A
100
RoW
Efemoral Vascular Scaffold System (EVSS)
Efemoral Medical, Inc.
Peripheral Arterial Disease, Vascular Diseases, Stenosis, Femoropopliteal Stenosis
03/26
03/28
Zaman, Zubayr
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arora, Reenu
ASLAN004-003, NCT05158023: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Completed
2
302
Europe, Canada, US, RoW
Placebo Comparator, ASLAN004
ASLAN Pharmaceuticals
Atopic Dermatitis
06/23
09/23
NCT06302426: Trial of INI-4001 in Patients With Advanced Solid Tumours

Not yet recruiting
1
50
RoW
INI-4001, Nivolumab, Opdivo, Pembrolizumab, Keytruda, Cemiplimab, Libtayo, Avelumab, Bavencio, Atezolizumab, Tecentriq, Durvalumab, Imfinzi
Inimmune Corporation, Avance Clinical Pty Ltd.
Advanced Solid Tumor
08/24
04/26
Khashram, Manar
PREVISION, NCT05556681: Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries

Active, not recruiting
N/A
34
RoW
BD™ Sirolimus Drug Coated Balloon Catheter percutaneous transluminal angioplasty
C. R. Bard
Peripheral Arterial Disease, Peripheral Artery Disease, Stenosis Artery
06/24
12/25
NCT05954793: A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)

Recruiting
N/A
30
RoW
JOTEC GmbH
Thoracoabdominal Aortic Aneurysm
08/24
01/25
WRAP, NCT05062291: Merit SODY™ Endoprosthesis for Treatment of Stenosis or Occlusion

Recruiting
N/A
500
Europe, RoW
Merit WRAPSODY Endovascular Stent Graft
Merit Medical Systems, Inc.
Venous Stenosis, Venous Occlusion
12/25
07/27
Efemoral I, NCT04584632: The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients with Symptomatic Peripheral Vascular Disease from Stenosis or Occlusion of the Femoropopliteal Artery

Recruiting
N/A
100
RoW
Efemoral Vascular Scaffold System (EVSS)
Efemoral Medical, Inc.
Peripheral Arterial Disease, Vascular Diseases, Stenosis, Femoropopliteal Stenosis
03/26
03/28
Zaman, Zubayr
No trials found

Download Options